United States HER2-negative Breast Cancer Market Report 2016

Publisher Name :
Date: 15-Sep-2016
No. of pages: 118
Inquire Before Buying

Notes:

Sales, means the sales volume of HER2-negative Breast Cancer

Revenue, means the sales value of HER2-negative Breast Cancer

This report studies sales (consumption) of HER2-negative Breast Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- F. Hoffmann-La Roche

- Novartis

- Pfizer

- AbbVie

- AstraZeneca

- BioMarin

- Bristol-Myers Squibb

- Eisai

- Eli Lilly

- Galena Biopharma

- Incyte

- Merck

- Merck Serono

- Merrimack

- Nektar

- Tesaro

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of HER2-negative Breast Cancer in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States HER2-negative Breast Cancer Market Report 2016

Table of Contents
United States HER2-negative Breast Cancer Market Report 2016
1 HER2-negative Breast Cancer Overview
1.1 Product Overview and Scope of HER2-negative Breast Cancer
1.2 Classification of HER2-negative Breast Cancer
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of HER2-negative Breast Cancer
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of HER2-negative Breast Cancer (2011-2021)
1.4.1 United States HER2-negative Breast Cancer Sales and Growth Rate (2011-2021)
1.4.2 United States HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
2 United States HER2-negative Breast Cancer Competition by Manufacturers
2.1 United States HER2-negative Breast Cancer Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States HER2-negative Breast Cancer Revenue and Share by Manufactures (2015 and 2016)
2.3 United States HER2-negative Breast Cancer Average Price by Manufactures (2015 and 2016)
2.4 HER2-negative Breast Cancer Market Competitive Situation and Trends
2.4.1 HER2-negative Breast Cancer Market Concentration Rate
2.4.2 HER2-negative Breast Cancer Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States HER2-negative Breast Cancer Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States HER2-negative Breast Cancer Sales and Market Share by Type (2011-2016)
3.2 United States HER2-negative Breast Cancer Revenue and Market Share by Type (2011-2016)
3.3 United States HER2-negative Breast Cancer Price by Type (2011-2016)
3.4 United States HER2-negative Breast Cancer Sales Growth Rate by Type (2011-2016)
4 United States HER2-negative Breast Cancer Sales (Volume) by Application (2011-2016)
4.1 United States HER2-negative Breast Cancer Sales and Market Share by Application (2011-2016)
4.2 United States HER2-negative Breast Cancer Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States HER2-negative Breast Cancer Manufacturers Profiles/Analysis
5.1 F. Hoffmann-La Roche
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 F. Hoffmann-La Roche HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Novartis
5.2.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Novartis HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Pfizer
5.3.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Pfizer HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 AbbVie
5.4.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 AbbVie HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 AstraZeneca
5.5.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 AstraZeneca HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 BioMarin
5.6.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 BioMarin HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Bristol-Myers Squibb
5.7.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Bristol-Myers Squibb HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Eisai
5.8.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Eisai HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eli Lilly
5.9.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eli Lilly HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Galena Biopharma
5.10.2 HER2-negative Breast Cancer Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Galena Biopharma HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Incyte
5.12 Merck
5.13 Merck Serono
5.14 Merrimack
5.15 Nektar
5.16 Tesaro
6 HER2-negative Breast Cancer Manufacturing Cost Analysis
6.1 HER2-negative Breast Cancer Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of HER2-negative Breast Cancer
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 HER2-negative Breast Cancer Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of HER2-negative Breast Cancer Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States HER2-negative Breast Cancer Market Forecast (2016-2021)
10.1 United States HER2-negative Breast Cancer Sales, Revenue Forecast (2016-2021)
10.2 United States HER2-negative Breast Cancer Sales Forecast by Type (2016-2021)
10.3 United States HER2-negative Breast Cancer Sales Forecast by Application (2016-2021)
10.4 HER2-negative Breast Cancer Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of HER2-negative Breast Cancer
Table Classification of HER2-negative Breast Cancer
Figure United States Sales Market Share of HER2-negative Breast Cancer by Type in 2015
Table Application of HER2-negative Breast Cancer
Figure United States Sales Market Share of HER2-negative Breast Cancer by Application in 2015
Figure United States HER2-negative Breast Cancer Sales and Growth Rate (2011-2021)
Figure United States HER2-negative Breast Cancer Revenue and Growth Rate (2011-2021)
Table United States HER2-negative Breast Cancer Sales of Key Manufacturers (2015 and 2016)
Table United States HER2-negative Breast Cancer Sales Share by Manufacturers (2015 and 2016)
Figure 2015 HER2-negative Breast Cancer Sales Share by Manufacturers
Figure 2016 HER2-negative Breast Cancer Sales Share by Manufacturers
Table United States HER2-negative Breast Cancer Revenue by Manufacturers (2015 and 2016)
Table United States HER2-negative Breast Cancer Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States HER2-negative Breast Cancer Revenue Share by Manufacturers
Table 2016 United States HER2-negative Breast Cancer Revenue Share by Manufacturers
Table United States Market HER2-negative Breast Cancer Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market HER2-negative Breast Cancer Average Price of Key Manufacturers in 2015
Figure HER2-negative Breast Cancer Market Share of Top 3 Manufacturers
Figure HER2-negative Breast Cancer Market Share of Top 5 Manufacturers
Table United States HER2-negative Breast Cancer Sales by Type (2011-2016)
Table United States HER2-negative Breast Cancer Sales Share by Type (2011-2016)
Figure United States HER2-negative Breast Cancer Sales Market Share by Type in 2015
Table United States HER2-negative Breast Cancer Revenue and Market Share by Type (2011-2016)
Table United States HER2-negative Breast Cancer Revenue Share by Type (2011-2016)
Figure Revenue Market Share of HER2-negative Breast Cancer by Type (2011-2016)
Table United States HER2-negative Breast Cancer Price by Type (2011-2016)
Figure United States HER2-negative Breast Cancer Sales Growth Rate by Type (2011-2016)
Table United States HER2-negative Breast Cancer Sales by Application (2011-2016)
Table United States HER2-negative Breast Cancer Sales Market Share by Application (2011-2016)
Figure United States HER2-negative Breast Cancer Sales Market Share by Application in 2015
Table United States HER2-negative Breast Cancer Sales Growth Rate by Application (2011-2016)
Figure United States HER2-negative Breast Cancer Sales Growth Rate by Application (2011-2016)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table BioMarin Basic Information List
Table BioMarin HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioMarin HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Eisai Basic Information List
Table Eisai HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Galena Biopharma Basic Information List
Table Galena Biopharma HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galena Biopharma HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Incyte Basic Information List
Table Incyte HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Incyte HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Merck Serono Basic Information List
Table Merck Serono HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Serono HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Merrimack Basic Information List
Table Merrimack HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merrimack HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Nektar Basic Information List
Table Nektar HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nektar HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Tesaro Basic Information List
Table Tesaro HER2-negative Breast Cancer Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tesaro HER2-negative Breast Cancer Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of HER2-negative Breast Cancer
Figure Manufacturing Process Analysis of HER2-negative Breast Cancer
Figure HER2-negative Breast Cancer Industrial Chain Analysis
Table Raw Materials Sources of HER2-negative Breast Cancer Major Manufacturers in 2015
Table Major Buyers of HER2-negative Breast Cancer
Table Distributors/Traders List
Figure United States HER2-negative Breast Cancer Production and Growth Rate Forecast (2016-2021)
Figure United States HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2016-2021)
Table United States HER2-negative Breast Cancer Production Forecast by Type (2016-2021)
Table United States HER2-negative Breast Cancer Consumption Forecast by Application (2016-2021)
  • Global Milk Allergy Clinical Trials Market Size, Status and Forecast 2022
    Published: 13-Dec-2017        Price: US 3300 Onwards        Pages: 93
    This report studies the global Milk Allergy Clinical Trials market, analyzes and researches the Milk Allergy Clinical Trials development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Mead Johnson - Danone SA - Perrigo Company - Abbott - Nestle - FrieslandCampina - Mylan - Sanofi - ALK Abello - Impax Market segment......
  • Global Intravenous Solutions Sales Market Report 2017
    Published: 13-Dec-2017        Price: US 4000 Onwards        Pages: 107
    In this report, the global Intravenous Solutions market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Intravenous Solutions for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - ......
  • Global Overactive Bladder Drug Market Size, Status and Forecast 2022
    Published: 13-Dec-2017        Price: US 3300 Onwards        Pages: 101
    This report studies the global Overactive Bladder Drug market, analyzes and researches the Overactive Bladder Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Astellas Pharma, Inc. (Japan) - Pfizer, Inc. (U.S.) - Teva Pharmaceutical Industries Limited (Israel) - Allergan, Plc (Ireland) - Medtronic plc (Ireland) - Mylan N.V. (U.S.) - En......
  • Global Abdominal Aortic Aneurysm Drug Sales Market Report 2017
    Published: 13-Dec-2017        Price: US 4000 Onwards        Pages: 108
    In this report, the global Abdominal Aortic Aneurysm Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Abdominal Aortic Aneurysm Drug for these regions, from 2012 to 2022 (forecast), covering - United States - China ......
  • Global Acinetobacter Infections Treatment Sales Market Report 2017
    Published: 13-Dec-2017        Price: US 4000 Onwards        Pages: 113
    In this report, the global Acinetobacter Infections Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Acinetobacter Infections Treatment for these regions, from 2012 to 2022 (forecast), covering - United States - China......
  • United States Venous Stents Market Report 2017
    Published: 13-Dec-2017        Price: US 3800 Onwards        Pages: 102
    In this report, the United States Venous Stents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Ve......
  • Global Adrenocorticotropic Hormone Receptor Sales Market Report 2017
    Published: 13-Dec-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Adrenocorticotropic Hormone Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Adrenocorticotropic Hormone Receptor for these regions, from 2012 to 2022 (forecast), covering - United States - C......
  • United States Injectable Fillers Market Report 2017
    Published: 13-Dec-2017        Price: US 3800 Onwards        Pages: 104
    In this report, the United States Injectable Fillers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate ......
  • United States Sheep Placenta Extract Market Report 2017
    Published: 13-Dec-2017        Price: US 3800 Onwards        Pages: 110
    In this report, the United States Sheep Placenta Extract market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth r......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs